Retrospective study to assess the efficacy and safety of checkpoint inhibitors in advanced urothelial carcinoma in real-world setting.

被引：0
|
作者：
Sevillano Fernandez, Elena
Puente, Javier
Vidal, Natalia
Pinto, Alvaro
Garcia Sanchez, Lourdes
Fiorini, Aldo
Chara Velarde, Luis Enrique
Nalda Ariza, Irene
Cassinello, Javier
Rodriguez, Angel
Galvan Ruiz, Saray
Francisco Rodriguez-Moreno, Juan
Barquin, Arantzazu
Ruiz, Sergio
Navarro, Paloma
Yague, Monica
Grande, Enrique
Garcia-Donas, Jesus
机构：
[1] HM Hosp, Madrid, Spain
[2] Hosp Univ Clin San Carlos, Madrid, Spain
[3] Hosp Clin San Carlos, Madrid, Spain
[4] La Paz Univ Hosp, Dept Med Oncol, Madrid, Spain
[5] Hosp Gen Segovia, Segovia, Spain
[6] Hosp Univ Guadalajara, Guadalajara, Spain
[7] Hosp Leon, Leon, Spain
[8] Hosp Univ Gran Canaria Doctor Negrin, Med Oncol Unit, Las Palmas Gran Canaria, Spain
[9] HM Hosp Ctr Integral Oncol Clara Campal, Madrid, Spain
[10] Lab Translat Oncol CIOCC, Madrid, Spain
[11] MD Anderson Canc Ctr, Madrid, Spain
[12] Fdn Hosp Madrid, Madrid, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17043
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Efficacy and Safety of Apatinib in Advanced Hepatocellular Carcinoma: A Multicenter Real World Retrospective Study
    Zheng, Zhuangzhuang
    Liu, Zijing
    Zhang, Haifeng
    Guo, Xiao
    Jia, Xiaojing
    Wang, Jianfeng
    Meng, Lingbin
    Xin, Ying
    Jiang, Xin
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [32] Efficacy and safety of angiogenesis inhibitors plus immune checkpoint inhibitors in advanced soft tissue sarcoma: a real-world, single-center study
    Liu, Zengjun
    Xu, Jing
    Liu, Mengyao
    Hu, Wenyu
    Xu, Ni
    Zhu, Dongyuan
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [33] Safety and Efficacy of Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma and End-Stage Renal Disease: Experiences From Real-World Practice
    Kuo, Ming-Chun
    Su, Po-Jung
    Huang, Chun-Chieh
    Luo, Hao-Lun
    Chiu, Tai-Jan
    Li, Shau-Hsuan
    Wu, Chia-Che
    Liu, Ting-Ting
    Cheng, Yuan-Tso
    Kang, Chih-Hsiung
    Su, Yu-Li
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [34] The efficacy and safety of pembrolizumab in advanced cervical cancer-A real world treatment study in an irish healthcare setting.
    Browne, Iseult
    Fennelly, David William
    Crown, John
    Murray, Hazel
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [35] Beyond atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma: overall efficacy and safety of tyrosine kinase inhibitors in a real-world setting
    Falette-Puisieux, Manon
    Nault, Jean-Charles
    Bouattour, Mohamed
    Lequoy, Marie
    Amaddeo, Giuliana
    Decaens, Thomas
    Di Fiore, Frederic
    Manfredi, Sylvain
    Merle, Philippe
    Baron, Aurore
    Locher, Christophe
    Pellat, Anna
    Coriat, Romain
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [36] Efficacy and safety of anlotinib with PD-1 inhibitors in the treatment of advanced hepatocellular carcinoma: A real-world study.
    Chen, Kehe
    Huang, Xianshi
    Yu, Lei
    Lu, Jianxun
    Huang, Fei
    Wang, Zhiguang
    Wei, Yan
    Hou, Encun
    Luo, Min
    Huang, Shiqing
    Hu, Hongbo
    Ou, Mei
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 583 - 583
  • [37] Health-Related Quality of Life in a Real-World Cohort of Patients with Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors
    Kobayashi, Hiroki
    Furubayashi, Nobuki
    Morihara, Kaede
    Nakamura, Motonobu
    Negishi, Takahito
    ONCOLOGY, 2025,
  • [38] Efficacy and safety of regorafenib and/or immune checkpoint inhibitors as a second-line therapy for advanced hepatocellular carcinoma: A real-world study from a single center.
    Liu, Songtao
    Huang, Xueying
    Chen, Jingjing
    Wei, Qiaoxin
    Liu, Mei
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [39] Real-world efficacy and safety of cabozantinib in Korean patients with advanced hepatocellular carcinoma: a multicenter retrospective analysis
    Bang, Yeong Hak
    Lee, Choong-kun
    Yoo, Changhoon
    Chon, Hong Jae
    Hong, Moonki
    Kang, Beodeul
    Kim, Hyung-Don
    Park, Sook Ryun
    Choi, Won-Mook
    Choi, Jonggi
    Lee, Danbi
    Shim, Ju Hyun
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Ryu, Min-Hee
    Ryoo, Baek-Yeol
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [40] Efficacy and safety of immune checkpoint inhibitors in advanced pancreatic cancer: A real world study in Chinese cohort
    Gong, Xiaoling
    Zhu, Yahui
    Zhang, Qianning
    Qiu, Xin
    Lu, Changchang
    Tong, Fan
    Wang, Qiaoli
    Kong, Weiwei
    Zhou, Haihui
    Liu, Baorui
    Zhou, Yujie
    Du, Juan
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (06)
12345